共 17 条
- [1] Dabigatran versus Warfarin in Patients with Atrial Fibrillation.[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12) : 1139 - 1151Connolly, Stuart J.论文数: 0 引用数: 0 h-index: 0机构: McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada Hamilton Hlth Sci, Hamilton, ON, Canada McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, CanadaEzekowitz, Michael D.论文数: 0 引用数: 0 h-index: 0机构: Lankenau Inst Med Res, Wynnewood, PA USA Ctr Heart, Wynnewood, PA USA McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, CanadaYusuf, Salim论文数: 0 引用数: 0 h-index: 0机构: McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada Hamilton Hlth Sci, Hamilton, ON, Canada McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada论文数: 引用数: h-index:机构:Oldgren, Jonas论文数: 0 引用数: 0 h-index: 0机构: Uppsala Clin Res Ctr, Uppsala, Sweden McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, CanadaParekh, Amit论文数: 0 引用数: 0 h-index: 0机构: Lankenau Inst Med Res, Wynnewood, PA USA Ctr Heart, Wynnewood, PA USA McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, CanadaPogue, Janice论文数: 0 引用数: 0 h-index: 0机构: McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada Hamilton Hlth Sci, Hamilton, ON, Canada McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, CanadaReilly, Paul A.论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, CanadaThemeles, Ellison论文数: 0 引用数: 0 h-index: 0机构: McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada Hamilton Hlth Sci, Hamilton, ON, Canada McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, CanadaVarrone, Jeanne论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, CanadaWang, Susan论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, CanadaAlings, Marco论文数: 0 引用数: 0 h-index: 0机构: Working Grp Cardiovasc Res Netherlands, Utrecht, Netherlands McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, CanadaXavier, Denis论文数: 0 引用数: 0 h-index: 0机构: St Johns Natl Acad Hlth Sci, Bangalore, Karnataka, India McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, CanadaZhu, Jun论文数: 0 引用数: 0 h-index: 0机构: FuWai Hosp, Beijing, Peoples R China McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, CanadaDiaz, Rafael论文数: 0 引用数: 0 h-index: 0机构: Estudios Clin Latinoamer, Rosario, Santa Fe, Argentina McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, CanadaLewis, Basil S.论文数: 0 引用数: 0 h-index: 0机构: Lady Davies Carmel Med Ctr, Haifa, Israel McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, CanadaDarius, Harald论文数: 0 引用数: 0 h-index: 0机构: Vivantes Klinikum Neukolln, Berlin, Germany McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, CanadaDiener, Hans-Christoph论文数: 0 引用数: 0 h-index: 0机构: Univ Duisburg Essen, Essen, Germany McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, CanadaJoyner, Campbell D.论文数: 0 引用数: 0 h-index: 0机构: Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, CanadaWallentin, Lars论文数: 0 引用数: 0 h-index: 0机构: Uppsala Clin Res Ctr, Uppsala, Sweden McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada
- [2] Restarting Dabigatran Etexilate 24 h After Reversal With Idarucizumab and Redosing Idarucizumab in Healthy Volunteers[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 1654 - 1656Glund, Stephan论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharma GmbH & Co KG, Birkendorfer Str 65, D-88397 Biberach, Germany Boehringer Ingelheim Pharma GmbH & Co KG, Birkendorfer Str 65, D-88397 Biberach, GermanyStangier, Joachim论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharma GmbH & Co KG, Birkendorfer Str 65, D-88397 Biberach, Germany Boehringer Ingelheim Pharma GmbH & Co KG, Birkendorfer Str 65, D-88397 Biberach, Germanyvan Ryn, Joanne论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharma GmbH & Co KG, Birkendorfer Str 65, D-88397 Biberach, Germany Boehringer Ingelheim Pharma GmbH & Co KG, Birkendorfer Str 65, D-88397 Biberach, GermanySchmohl, Michael论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharma GmbH & Co KG, Birkendorfer Str 65, D-88397 Biberach, Germany Boehringer Ingelheim Pharma GmbH & Co KG, Birkendorfer Str 65, D-88397 Biberach, GermanyMoschetti, Viktoria论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharma GmbH & Co KG, Birkendorfer Str 65, D-88397 Biberach, Germany Boehringer Ingelheim Pharma GmbH & Co KG, Birkendorfer Str 65, D-88397 Biberach, GermanyHaazen, Wouter论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharma GmbH & Co KG, Birkendorfer Str 65, D-88397 Biberach, Germany Boehringer Ingelheim Pharma GmbH & Co KG, Birkendorfer Str 65, D-88397 Biberach, GermanyDe Smet, Marina论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharma GmbH & Co KG, Birkendorfer Str 65, D-88397 Biberach, Germany Boehringer Ingelheim Pharma GmbH & Co KG, Birkendorfer Str 65, D-88397 Biberach, GermanyGansser, Dietmar论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharma GmbH & Co KG, Birkendorfer Str 65, D-88397 Biberach, Germany Boehringer Ingelheim Pharma GmbH & Co KG, Birkendorfer Str 65, D-88397 Biberach, GermanyNorris, Stephen论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharma GmbH & Co KG, Birkendorfer Str 65, D-88397 Biberach, Germany Boehringer Ingelheim Pharma GmbH & Co KG, Birkendorfer Str 65, D-88397 Biberach, GermanyLang, Benjamin论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharma GmbH & Co KG, Birkendorfer Str 65, D-88397 Biberach, Germany Boehringer Ingelheim Pharma GmbH & Co KG, Birkendorfer Str 65, D-88397 Biberach, GermanyReilly, Paul论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharma GmbH & Co KG, Birkendorfer Str 65, D-88397 Biberach, Germany Boehringer Ingelheim Pharma GmbH & Co KG, Birkendorfer Str 65, D-88397 Biberach, GermanyKreuzer, Joerg论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharma GmbH & Co KG, Birkendorfer Str 65, D-88397 Biberach, Germany Boehringer Ingelheim Pharma GmbH & Co KG, Birkendorfer Str 65, D-88397 Biberach, Germany
- [3] Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial[J]. LANCET, 2015, 386 (9994) : 680 - 690Glund, Stephan论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharma GmbH & Co KG, D-88397 Biberach, Germany Boehringer Ingelheim Pharma GmbH & Co KG, D-88397 Biberach, GermanyStangier, Joachim论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharma GmbH & Co KG, D-88397 Biberach, Germany Boehringer Ingelheim Pharma GmbH & Co KG, D-88397 Biberach, GermanySchmohl, Michael论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharma GmbH & Co KG, D-88397 Biberach, Germany Boehringer Ingelheim Pharma GmbH & Co KG, D-88397 Biberach, GermanyGansser, Dietmar论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharma GmbH & Co KG, D-88397 Biberach, Germany Boehringer Ingelheim Pharma GmbH & Co KG, D-88397 Biberach, GermanyNorris, Stephen论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA Boehringer Ingelheim Pharma GmbH & Co KG, D-88397 Biberach, Germanyvan Ryn, Joanne论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharma GmbH & Co KG, D-88397 Biberach, Germany Boehringer Ingelheim Pharma GmbH & Co KG, D-88397 Biberach, GermanyLang, Benjamin论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharma GmbH & Co KG, D-88397 Biberach, Germany Boehringer Ingelheim Pharma GmbH & Co KG, D-88397 Biberach, GermanyRamael, Steven论文数: 0 引用数: 0 h-index: 0机构: SGS Life Sci Clin Res Serv, Clin Pharmacol Unit, Antwerp, Belgium Boehringer Ingelheim Pharma GmbH & Co KG, D-88397 Biberach, GermanyMoschetti, Viktoria论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany Boehringer Ingelheim Pharma GmbH & Co KG, D-88397 Biberach, GermanyGruenenfelder, Fredrik论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany Boehringer Ingelheim Pharma GmbH & Co KG, D-88397 Biberach, GermanyReilly, Paul论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA Boehringer Ingelheim Pharma GmbH & Co KG, D-88397 Biberach, GermanyKreuzer, Joerg论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany Boehringer Ingelheim Pharma GmbH & Co KG, D-88397 Biberach, Germany
- [4] A randomised study in healthy volunteers to investigate the safety, tolerability and pharmacokinetics of idarucizumab, a specific antidote to dabigatran[J]. THROMBOSIS AND HAEMOSTASIS, 2015, 113 (05) : 943 - 951Glund, Stephan论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, GermanyMoschetti, Viktoria论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, GermanyNorris, Stephen论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT USA Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, GermanyStangier, Joachim论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, GermanySchmohl, Michael论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germanyvan Ryn, Joanne论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, GermanyLang, Benjamin论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, GermanyRamael, Steven论文数: 0 引用数: 0 h-index: 0机构: SGS Life Sci Serv, Clin Pharmacol Unit, Antwerp, Belgium Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, GermanyReilly, Paul论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT USA Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany
- [5] Cardiovascular, Bleeding, and Mortality Risks in Elderly Medicare Patients Treated With Dabigatran or Warfarin for Nonvalvular Atrial Fibrillation[J]. CIRCULATION, 2015, 131 (02) : 157 - 164Graham, David J.论文数: 0 引用数: 0 h-index: 0机构: US FDA, Off Surveillance & Epidemiol, Ctr Drug Evaluat & Res, Silver Spring, MD USA US FDA, Off Surveillance & Epidemiol, Ctr Drug Evaluat & Res, Silver Spring, MD USAReichman, Marsha E.论文数: 0 引用数: 0 h-index: 0机构: US FDA, Off Surveillance & Epidemiol, Ctr Drug Evaluat & Res, Silver Spring, MD USA US FDA, Off Surveillance & Epidemiol, Ctr Drug Evaluat & Res, Silver Spring, MD USAWernecke, Michael论文数: 0 引用数: 0 h-index: 0机构: Acumen LLC, Burlingame, CA USA US FDA, Off Surveillance & Epidemiol, Ctr Drug Evaluat & Res, Silver Spring, MD USAZhang, Rongmei论文数: 0 引用数: 0 h-index: 0机构: US FDA, Off Biostat, Ctr Drug Evaluat & Res, Silver Spring, MD USA US FDA, Off Surveillance & Epidemiol, Ctr Drug Evaluat & Res, Silver Spring, MD USASouthworth, Mary Ross论文数: 0 引用数: 0 h-index: 0机构: US FDA, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA US FDA, Off Surveillance & Epidemiol, Ctr Drug Evaluat & Res, Silver Spring, MD USALevenson, Mark论文数: 0 引用数: 0 h-index: 0机构: US FDA, Off Biostat, Ctr Drug Evaluat & Res, Silver Spring, MD USA US FDA, Off Surveillance & Epidemiol, Ctr Drug Evaluat & Res, Silver Spring, MD USASheu, Ting-Chang论文数: 0 引用数: 0 h-index: 0机构: Acumen LLC, Burlingame, CA USA US FDA, Off Surveillance & Epidemiol, Ctr Drug Evaluat & Res, Silver Spring, MD USAMott, Katrina论文数: 0 引用数: 0 h-index: 0机构: US FDA, Off Surveillance & Epidemiol, Ctr Drug Evaluat & Res, Silver Spring, MD USA US FDA, Off Surveillance & Epidemiol, Ctr Drug Evaluat & Res, Silver Spring, MD USAGoulding, Margie R.论文数: 0 引用数: 0 h-index: 0机构: US FDA, Off Surveillance & Epidemiol, Ctr Drug Evaluat & Res, Silver Spring, MD USA US FDA, Off Surveillance & Epidemiol, Ctr Drug Evaluat & Res, Silver Spring, MD USAHoustoun, Monika论文数: 0 引用数: 0 h-index: 0机构: US FDA, Off Surveillance & Epidemiol, Ctr Drug Evaluat & Res, Silver Spring, MD USA US FDA, Off Surveillance & Epidemiol, Ctr Drug Evaluat & Res, Silver Spring, MD USAMaCurdy, Thomas E.论文数: 0 引用数: 0 h-index: 0机构: Acumen LLC, Burlingame, CA USA Stanford Univ, Dept Econ, Stanford, CA 94305 USA US FDA, Off Surveillance & Epidemiol, Ctr Drug Evaluat & Res, Silver Spring, MD USAWorrall, Chris论文数: 0 引用数: 0 h-index: 0机构: Ctr Medicare Serv, Washington, DC USA Ctr Medicaid Serv, Washington, DC USA US FDA, Off Surveillance & Epidemiol, Ctr Drug Evaluat & Res, Silver Spring, MD USAKelman, Jeffrey A.论文数: 0 引用数: 0 h-index: 0机构: Ctr Medicare Serv, Washington, DC USA Ctr Medicaid Serv, Washington, DC USA US FDA, Off Surveillance & Epidemiol, Ctr Drug Evaluat & Res, Silver Spring, MD USA
- [6] Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation A RE-LY (Randomized Evaluation of Long-term Anticoagulation Therapy) Trial Analysis[J]. CIRCULATION, 2014, 129 (09) : 961 - 970Hijazi, Ziad论文数: 0 引用数: 0 h-index: 0机构: Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden Uppsala Univ, Dept Med Sci, Uppsala, Sweden Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, SwedenHohnloser, Stefan H.论文数: 0 引用数: 0 h-index: 0机构: Goethe Univ Frankfurt, Dept Cardiol, D-60054 Frankfurt, Germany Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, SwedenOldgren, Jonas论文数: 0 引用数: 0 h-index: 0机构: Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden Uppsala Univ, Dept Med Sci, Uppsala, Sweden Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, SwedenAndersson, Ulrika论文数: 0 引用数: 0 h-index: 0机构: Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, SwedenConnolly, Stuart J.论文数: 0 引用数: 0 h-index: 0机构: Populat Hlth Res Inst, Hamilton, ON, Canada Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, SwedenEikelboom, John W.论文数: 0 引用数: 0 h-index: 0机构: Populat Hlth Res Inst, Hamilton, ON, Canada Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, SwedenEzekowitz, Michael D.论文数: 0 引用数: 0 h-index: 0机构: Thomas Jefferson Med Coll, Wynnewood, PA USA Ctr Heart, Wynnewood, PA USA Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, SwedenReilly, Paul A.论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharmaceut, Ridgefield, CT USA Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, SwedenSiegbahn, Agneta论文数: 0 引用数: 0 h-index: 0机构: Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden Uppsala Univ, Dept Med Sci, Uppsala, Sweden Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, SwedenYusuf, Salim论文数: 0 引用数: 0 h-index: 0机构: Populat Hlth Res Inst, Hamilton, ON, Canada Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, SwedenWallentin, Lars论文数: 0 引用数: 0 h-index: 0机构: Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden Uppsala Univ, Dept Med Sci, Uppsala, Sweden Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden
- [7] Management and Outcomes of Major Bleeding During Treatment With Dabigatran or Warfarin[J]. CIRCULATION, 2013, 128 (21) : 2325 - 2332Majeed, Ammar论文数: 0 引用数: 0 h-index: 0机构: Karolinska Univ Hosp, Coagulat Unit, Hematol Ctr, Stockholm, Sweden Karolinska Inst, Stockholm, Sweden Karolinska Univ Hosp, Coagulat Unit, Hematol Ctr, Stockholm, SwedenHwang, Hun-Gyu论文数: 0 引用数: 0 h-index: 0机构: Soonchunhyang Univ, Gumis Hosp, Dept Med, Chungcheongnam Do, North Kyungsang, South Korea Karolinska Univ Hosp, Coagulat Unit, Hematol Ctr, Stockholm, SwedenConnolly, Stuart J.论文数: 0 引用数: 0 h-index: 0机构: McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada Karolinska Univ Hosp, Coagulat Unit, Hematol Ctr, Stockholm, SwedenEikelboom, John W.论文数: 0 引用数: 0 h-index: 0机构: McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada Karolinska Univ Hosp, Coagulat Unit, Hematol Ctr, Stockholm, SwedenEzekowitz, Michael D.论文数: 0 引用数: 0 h-index: 0机构: Thomas Jefferson Med Coll, Lankenau Med Ctr, Wynnewood, PA USA Karolinska Univ Hosp, Coagulat Unit, Hematol Ctr, Stockholm, SwedenWallentin, Lars论文数: 0 引用数: 0 h-index: 0机构: Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden Uppsala Univ, Dept Med Sci, Uppsala, Sweden Karolinska Univ Hosp, Coagulat Unit, Hematol Ctr, Stockholm, SwedenBrueckmann, Martina论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany Heidelberg Univ, Fac Med Mannheim, Mannheim, Germany Karolinska Univ Hosp, Coagulat Unit, Hematol Ctr, Stockholm, SwedenFraessdorf, Mandy论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany Karolinska Univ Hosp, Coagulat Unit, Hematol Ctr, Stockholm, SwedenYusuf, Salim论文数: 0 引用数: 0 h-index: 0机构: McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada Karolinska Univ Hosp, Coagulat Unit, Hematol Ctr, Stockholm, SwedenSchulman, Sam论文数: 0 引用数: 0 h-index: 0机构: Karolinska Univ Hosp, Coagulat Unit, Hematol Ctr, Stockholm, Sweden Karolinska Inst, Stockholm, Sweden McMaster Univ, Dept Med, Hamilton, ON, Canada Thrombosis & Atherosclerosis Res Inst, Hamilton, ON, Canada Karolinska Univ Hosp, Coagulat Unit, Hematol Ctr, Stockholm, Sweden
- [8] Idarucizumab for Dabigatran Reversal[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (06) : 511 - 520Pollack, Charles V., Jr.论文数: 0 引用数: 0 h-index: 0机构: Penn Hosp, Philadelphia, PA 19107 USA Penn Hosp, Philadelphia, PA 19107 USAReilly, Paul A.论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA Penn Hosp, Philadelphia, PA 19107 USA论文数: 引用数: h-index:机构:Glund, Stephan论文数: 0 引用数: 0 h-index: 0机构: Univ Heidelberg Hosp, Boehringer Ingelheim Pharma, Biberach, Germany Penn Hosp, Philadelphia, PA 19107 USAVerhamme, Peter论文数: 0 引用数: 0 h-index: 0机构: Univ Leuven, Leuven, Belgium Penn Hosp, Philadelphia, PA 19107 USABernstein, Richard A.论文数: 0 引用数: 0 h-index: 0机构: Northwestern Univ, Chicago, IL 60611 USA Penn Hosp, Philadelphia, PA 19107 USADubiel, Robert论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA Penn Hosp, Philadelphia, PA 19107 USAHuisman, Menno V.论文数: 0 引用数: 0 h-index: 0机构: Leiden Univ, Med Ctr, Leiden, Netherlands Penn Hosp, Philadelphia, PA 19107 USAHylek, Elaine M.论文数: 0 引用数: 0 h-index: 0机构: Boston Univ, Sch Med, Boston, MA 02215 USA Penn Hosp, Philadelphia, PA 19107 USAKamphuisen, Pieter W.论文数: 0 引用数: 0 h-index: 0机构: Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands Penn Hosp, Philadelphia, PA 19107 USAKreuzer, Jrg论文数: 0 引用数: 0 h-index: 0机构: Univ Heidelberg Hosp, Ingelheim, Frankfurt, Germany Penn Hosp, Philadelphia, PA 19107 USALevy, Jerrold H.论文数: 0 引用数: 0 h-index: 0机构: Duke Univ, Med Ctr, Durham, NC USA Penn Hosp, Philadelphia, PA 19107 USASellke, Frank W.论文数: 0 引用数: 0 h-index: 0机构: Brown Med Sch, Providence, RI USA Rhode Isl Hosp, Providence, RI USA Penn Hosp, Philadelphia, PA 19107 USAStangier, Joachim论文数: 0 引用数: 0 h-index: 0机构: Univ Heidelberg Hosp, Boehringer Ingelheim Pharma, Biberach, Germany Penn Hosp, Philadelphia, PA 19107 USASteiner, Thorsten论文数: 0 引用数: 0 h-index: 0机构: Univ Heidelberg Hosp, Klinikum Frankfurt Hochst, Heidelberg, Germany Penn Hosp, Philadelphia, PA 19107 USAWang, Bushi论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA Penn Hosp, Philadelphia, PA 19107 USAKam, Chak-Wah论文数: 0 引用数: 0 h-index: 0机构: Tuen Mun Hosp, Tuen Mun, NT, Peoples R China Penn Hosp, Philadelphia, PA 19107 USAWeitz, Jeffrey I.论文数: 0 引用数: 0 h-index: 0机构: McMaster Univ, Hamilton, ON, Canada Thrombosis & Atherosclerosis Res Inst, Hamilton, ON, Canada Penn Hosp, Philadelphia, PA 19107 USA
- [9] Novel oral anticoagulants and reversal agents: Considerations for clinical development[J]. AMERICAN HEART JOURNAL, 2015, 169 (06) : 751 - 757Sarich, Troy C.论文数: 0 引用数: 0 h-index: 0机构: Janssen Sci Affairs LLC, Titusville, NJ USA Janssen Sci Affairs LLC, Titusville, NJ USASeltzer, Jonathan H.论文数: 0 引用数: 0 h-index: 0机构: ACI Clin & Lankenau Heart Inst, Wynnewood, PA USA Janssen Sci Affairs LLC, Titusville, NJ USABerkowitz, Scott D.论文数: 0 引用数: 0 h-index: 0机构: Bayer HealthCare Pharmaceut Inc, Whippany, NJ USA Janssen Sci Affairs LLC, Titusville, NJ USACostin, James论文数: 0 引用数: 0 h-index: 0机构: Perosphere Inc, Danbury, CT USA Janssen Sci Affairs LLC, Titusville, NJ USACurnutte, John T.论文数: 0 引用数: 0 h-index: 0机构: Portola Pharmaceut Inc, San Francisco, CA USA Janssen Sci Affairs LLC, Titusville, NJ USAGibson, C. Michael论文数: 0 引用数: 0 h-index: 0机构: Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA Janssen Sci Affairs LLC, Titusville, NJ USAHoffman, Maureane论文数: 0 引用数: 0 h-index: 0机构: Durham Vet Affairs Med Ctr, Pathol & Lab Med Serv, Durham, NC USA Janssen Sci Affairs LLC, Titusville, NJ USAKaminskas, Edvardas论文数: 0 引用数: 0 h-index: 0机构: US FDA, Div Hematol Prod, CDER, Silver Spring, MD USA Janssen Sci Affairs LLC, Titusville, NJ USAKrucoff, Mitchell W.论文数: 0 引用数: 0 h-index: 0机构: Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA Janssen Sci Affairs LLC, Titusville, NJ USALevy, Jerrold H.论文数: 0 引用数: 0 h-index: 0机构: Duke Univ, Sch Med, Durham, NC USA Janssen Sci Affairs LLC, Titusville, NJ USAMintz, Paul D.论文数: 0 引用数: 0 h-index: 0机构: US FDA, Div Hematol Clin Review, Off Blood Res & Review, CBER, Silver Spring, MD USA Janssen Sci Affairs LLC, Titusville, NJ USAReilly, Paul A.论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA Janssen Sci Affairs LLC, Titusville, NJ USASager, Philip T.论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, San Francisco, CA USA Sager Consulting Experts, San Francisco, CA USA Janssen Sci Affairs LLC, Titusville, NJ USASinger, Daniel E.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA Harvard Univ, Sch Med, Boston, MA USA Janssen Sci Affairs LLC, Titusville, NJ USAStockbridge, Norman论文数: 0 引用数: 0 h-index: 0机构: US FDA, Div Cardiovasc & Renal Prod, CDER, Silver Spring, MD USA Janssen Sci Affairs LLC, Titusville, NJ USAWeitz, Jeffrey I.论文数: 0 引用数: 0 h-index: 0机构: McMaster Univ, Hamilton, ON, Canada Thrombosis & Atherosclerosis Res Inst, Hamilton, ON, Canada Janssen Sci Affairs LLC, Titusville, NJ USAKowey, Peter R.论文数: 0 引用数: 0 h-index: 0机构: Lankenau Heart Inst, Philadelphia, PA USA Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA Janssen Sci Affairs LLC, Titusville, NJ USA
- [10] A specific antidote for dabigatran: functional and structural characterization[J]. BLOOD, 2013, 121 (18) : 3554 - 3562Schiele, Felix论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim GmbH & Co KG, Struct Res Grp, D-88397 Biberach, Germany Boehringer Ingelheim GmbH & Co KG, Struct Res Grp, D-88397 Biberach, Germanyvan Ryn, Joanne论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim GmbH & Co KG, CardioMetab Dis Res, D-88397 Biberach, Germany Boehringer Ingelheim GmbH & Co KG, Struct Res Grp, D-88397 Biberach, GermanyCanada, Keith论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharmaceut Inc, Biotherapeut, Ridgefield, CT 06877 USA Boehringer Ingelheim GmbH & Co KG, Struct Res Grp, D-88397 Biberach, GermanyNewsome, Corey论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharmaceut Inc, Biotherapeut, Ridgefield, CT 06877 USA Boehringer Ingelheim GmbH & Co KG, Struct Res Grp, D-88397 Biberach, GermanySepulveda, Eliud论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharmaceut Inc, Biotherapeut, Ridgefield, CT 06877 USA Boehringer Ingelheim GmbH & Co KG, Struct Res Grp, D-88397 Biberach, GermanyPark, John论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim GmbH & Co KG, New Biol Entity Discovery, D-88397 Biberach, Germany Boehringer Ingelheim GmbH & Co KG, Struct Res Grp, D-88397 Biberach, GermanyNar, Herbert论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim GmbH & Co KG, Struct Res Grp, D-88397 Biberach, Germany Boehringer Ingelheim GmbH & Co KG, Struct Res Grp, D-88397 Biberach, GermanyLitzenburger, Tobias论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim GmbH & Co KG, New Biol Entity Discovery, D-88397 Biberach, Germany Boehringer Ingelheim GmbH & Co KG, Struct Res Grp, D-88397 Biberach, Germany